Webinar Replay about the Event Ensuring responsible sourcing of our goods and services is paramount for continuous improvement of our performance as outlined in our Corporate Social Responsibility framework. Learn […]
Webinar Replay about the Event In 2021, Bachem acquired the first two process-scale Multicolumn Counter-current Solvent Gradient Purification (MCSGP) systems for the purification of peptides and oligonucleotides. The systems are […]
Webinar Replay about the Event At Bachem, we are constantly striving to improve our industry standards by developing innovative and efficient large-scale manufacturing processes for active pharmaceutical ingredients (APIs). Thereby, […]
about the Event In this webinar we will present direct, robust and easy-to-use techniques to fully characterize the nucleotide sequence of highly modified single-stranded RNAs by top down tandem MS. […]
Which of the current available production techniques should be chosen for long, complex and functionalized peptides or even small proteins? Which technologies allow functionalization of peptides? Get answers to these […]
Based on decades of experience in applying stirred-bed reactors for making peptides, we investigated whether these could be used for the manufacturing of oligonucleotides as well. Join our webinar on […]
Aggregation is a complex and heterogenous process for peptides. The individual trigger for peptide aggregation is peptide specific and can be induced by standard manufacturing conditions. Therefore, it is important to evaluate […]
Which of the current available production techniques should be chosen for long, complex and functionalized peptides or even small proteins? Which technologies allow functionalization of peptides? Get answers to these […]
Learn more on Bachem’s new one-pot process of synthesizing oligonucleotides in liquid-phase utilizing new pseudo-solid-phase protecting groups (tags). This process holds promise to be more efficient and environmentally friendly than […]
Throughout industry the trend goes from producing batches to continuous production. Due to the increasing need for efficient methods to produce peptides and oligonucleotides on a large scale, Bachem was […]
We asked ourselves how will we need to transform and further develop PM capabilities and services to best support BACHEM‘s growth aspirations?
Cysteine (Cys) is a key amino acid in many therapeutic peptides. Cys amino acid residues, involved in the formation of two important peptide bonds, the amide and disulfide bonds, and […]
